Related Experiment Video
Updated: Jul 15, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Current issues in quality improvement in cystic fibrosis
Hebe B Quinton1, Gerald T O'Connor
1Clinical Research Section, Department of Medicine, Dartmouth Medical School, One Medical Center Drive, Lebanon, NH 03756, USA. hebe.b.quinton@dartmouth.edu
Quality improvement (QI) in cystic fibrosis (CF) relies on guidelines and data for progress. This article explores QI history, methods, and the impact of data transparency in CF care.
Area of Science:
- Medical research
- Healthcare quality improvement
- Cystic Fibrosis research
Background:
- Modern cystic fibrosis (CF) care has seen continuous improvement.
- Guidelines and evidence-based medicine guide improvement efforts.
- Data and measurement are crucial for quality improvement (QI) in healthcare.
Purpose of the Study:
- To describe the history and context of QI in CF.
- To illustrate the use of guidelines and data in CF care.
- To explore approaches for developing QI skills and implementing changes in CF clinics.
Main Methods:
- Review of QI history and principles in CF.
- Examples from a regional consortium's work on guidelines and data.
- Discussion of QI skill development and change management strategies.
- Analysis of public reporting and data transparency benefits.
Main Results:
- QI is integral to the advancement of CF care.
- Guidelines and data serve as essential tools for tracking progress.
- Developing QI skills is key to successful implementation of changes in CF clinics.
- Public reporting and data transparency can enhance accountability and outcomes.
Conclusions:
- Continuous quality improvement is a hallmark of modern CF management.
- Integrating data and evidence-based guidelines drives progress in CF care.
- Strategic implementation of QI initiatives and transparent reporting are vital for optimizing CF patient outcomes.
More Related Videos
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History